Not Yet RecruitingNot Applicable

Study Comparing Atomizerd Midazolam & Fentanyl and Dexmedomidine for Procedural Sedation in Adult and Pediatric Patient (2 to 60 Years Old)

Oman128 participantsStarted 2025-09-01

Plain-language summary

To evaluate the depth of sedation, as well as onset, and recovery times, satisfaction of sedation , adverse events associated with Atomized Midazolam \& Fentanyl and Dexmedetomidine during procedural sedation in a diverse population spanning from 2 to 60 years old at these three prominent Omani healthcare facilities.

Who can participate

Age range2 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients aged 2 to 60 years.
✓. Patients undergoing EM procedures requiring sedation.

Exclusion criteria

✕. Patients with contraindications to any of the sedation agents being studied.
✕. Patients with a history of adverse reactions or allergies to the study medications.
✕. Drug interactions: Patients taking certain medications that may interact adversely with the study medications.
✕. Drug Abuser
✕. Pregnancy and breastfeeding
✕. Patients with significant cardiovascular or respiratory compromise.
✕. Patients with nasal disorder (nasal trauma, epistaxis)
✕. Patients unable to provide informed consent or those with cognitive impairment.

What they're measuring

depth of sedtion

Timeframe: 1 year

Trial details

NCT IDNCT07166666

SponsorOman Medical Speciality Board

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2026-09-30

Contact for this trial

Ghaliy khamis al noofli, MD

+96895751564 r23029@resident.omsb.org

View on ClinicalTrials.gov More Sedation trials